The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis
Open accessAbstract
Research into the heterogeneous nature of cognitive impairment documented in patients with Parkinson’s disease (PD) has focused on disentangling deficits that vary between individuals, evolve and respond differentially to pharmacological treatments, and relate differentially to PD dementia (PDD). We summarise studies conducted in our laboratory over the last 2 decades, outlining the incremental development of our hypotheses, the starting point for which is our early work on executive deficits mirroring fronto-striatal dysfunction. We present subsequent findings linking these deficits to a model of dopaminergic function that conforms to an inverted curvilinear function. We review studies that investigated the range of dopamine-independent attentional and visuospatial memory deficits seen in PD, demonstrating that abnormalities in these domains more accurately predict PDD. We conclude with an exposition of the dual syndrome hypothesis, which distinguishes between dopaminergically mediated fronto-striatal executive impairments and a dementia syndrome with distinctive prodromal visuospatial deficits in which cholinergic treatments offer some clinical benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
The relation of strength of stimulus to rapidity of habit formation
Yerkes, R. M., & Dodson, J. D. (1908) · Journal of Comparative Neurology and Psychology · doi:10.1002/cne.920180503 · Cited by 6,911
Getting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Planning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,245
Self-citationRivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., Durif, F., Kulisevsky, J., van Laar, T., Lees, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,223
Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., McInnes, L., & Rabbitt, P. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106735 · Cited by 1,078
Self-citationZarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 965
Self-citationThe Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957
Self-citationEvolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934
Self-citationCools, R. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1136 · Cited by 906
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893
FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASE: THE CORTICAL FOCUS OF NEOSTRIATAL OUTFLOW
TAYLOR, A. E., SAINT-CYR, J. A., & LANG, A. E. (1986) · Brain · doi:10.1093/brain/109.5.845 · Cited by 882
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Self-citationFRONTO-STRIATAL COGNITIVE DEFICITS AT DIFFERENT STAGES OF PARKINSON'S DISEASE
OWEN, A. M., JAMES, M., LEIGH, P. N., SUMMERS, B. A., MARSDEN, C. D., QUINN, N. P., LANGE, K. W., & ROBBINS, T. W. (1992) · Brain · doi:10.1093/brain/115.6.1727 · Cited by 868
Self-citation‘Frontal' cognitive function in patients with Parkinson's disease ‘on' and ‘off' levodopa
GOTHAM, A. M., BROWN, R. G., & MARSDEN, C. D. (1988) · Brain · doi:10.1093/brain/111.2.299 · Cited by 835
Cools, R., Clark, L., Owen, A. M., & Robbins, T. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04563.2002 · Cited by 784
Self-citationRogers, R. D., Owen, A. M., Middleton, H. C., Williams, E. J., Pickard, J. D., Sahakian, B. J., & Robbins, T. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-09029.1999 · Cited by 747
Self-citationScatton, B., Javoy-Agid, F., Rouquier, L., Dubois, B., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90993-9 · Cited by 726
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2004) · Brain · doi:10.1093/brain/awh067 · Cited by 688
Self-citationPathology of Parkinson’s disease: Changes other than the nigrostriatal pathway
Jellinger, K. A. (1991) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159935 · Cited by 684
SAHAKIAN, B. J., MORRIS, R. G., EVENDEN, J. L., HEALD, A., LEVY, R., PHILPOT, M., & ROBBINS, T. W. (1988) · Brain · doi:10.1093/brain/111.3.695 · Cited by 666
Self-citationOwen, A. M., Roberts, A. C., Hodges, J. R., & Robbins, T. W. (1993) · Brain · doi:10.1093/brain/116.5.1159 · Cited by 639
Self-citationLange, K. W., Robbins, T. W., Marsden, C. D., James, M., Owen, A. M., & Paul, G. M. (1992) · Psychopharmacology · doi:10.1007/bf02245167 · Cited by 610
Self-citationDepression, intellectual impairment, and Parkinson disease
Mayeux, R., Stern, Y., Rosen, J., & Leventhal, J. (1981) · Neurology · doi:10.1212/wnl.31.6.645 · Cited by 572
Bohnen, N. I., Kaufer, D. I., Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G., Mathis, C. A., Moore, R. Y., & DeKosky, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1745 · Cited by 551
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
Lewis, S. J. G. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033530 · Cited by 551
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
Pycock, C. J., Kerwin, R. W., & Carter, C. J. (1980) · Nature · doi:10.1038/286074a0 · Cited by 549
Lewis, S. J. G., Dove, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06351.2003 · Cited by 532
Self-citationDownes, J. J., Roberts, A. C., Sahakian, B. J., Evenden, J. L., Morris, R. G., & Robbins, T. W. (1989) · Neuropsychologia · doi:10.1016/0028-3932(89)90128-0 · Cited by 527
Self-citationCools, R., Barker, R. A., Sahakian, B. J., & Robbins, T. W. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(03)00117-9 · Cited by 516
Self-citationChan‐Palay, V., & Asan, E. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902870308 · Cited by 495
Swainson, R., Rogers, R. D., Sahakian, B. J., Summers, B. A., Polkey, C. E., & Robbins, T. W. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00103-7 · Cited by 494
Self-citationRoberts, A., De Salvia, M., Wilkinson, L., Collins, P., Muir, J., Everitt, B., & Robbins, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02531.1994 · Cited by 415
Self-citationLearning and cognitive flexibility: frontostriatal function and monoaminergic modulation
Kehagia, A. A., Murray, G. K., & Robbins, T. W. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.01.007 · Cited by 398
Self-citationCools, R., Stefanova, E., Barker, R. A., Robbins, T. W., & Owen, A. M. (2002) · Brain · doi:10.1093/brain/awf052 · Cited by 396
Self-citationPlanning and spatial working memory in Parkinson's disease.
Morris, R. G., Downes, J. J., Sahakian, B. J., Evenden, J. L., Heald, A., & Robbins, T. W. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.757 · Cited by 359
Self-citationDetecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer’s Disease
Blackwell, A. D., Sahakian, B. J., Vesey, R., Semple, J. M., Robbins, T. W., & Hodges, J. R. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074081 · Cited by 341
Self-citationLewis, S. J. G., Slabosz, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.10.001 · Cited by 309
Self-citationThe association of incident dementia with mortality in PD
Levy, G., Tang, M.-X., Louis, E. D., Côté, L. J., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2002) · Neurology · doi:10.1212/01.wnl.0000036610.36834.e0 · Cited by 297
Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease.
Owen, A. M., Sahakian, B. J., Hodges, J. R., Summers, B. A., Polkey, C. E., & Robbins, T. W. (1995) · Neuropsychology · doi:10.1037//0894-4105.9.1.126 · Cited by 294
Self-citationL-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease
Cools, R., Lewis, S. J. G., Clark, L., Barker, R. A., & Robbins, T. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301153 · Cited by 289
Self-citationCOOPER, J. A., SAGAR, H. J., DOHERTY, S. M., JORDAN, N., TIDSWELL, P., & SULLIVAN, E. V. (1992) · Brain · doi:10.1093/brain/115.6.1701 · Cited by 275
Robbins, T. W., James, M., Owen, A. M., Lange, K. W., Lees, A. J., Leigh, P. N., Marsden, C. D., Quinn, N. P., & Summers, B. A. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.1.79 · Cited by 272
Self-citationTau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease
Goris, A., Williams‐Gray, C. H., Clark, G. R., Foltynie, T., Lewis, S. J. G., Brown, J., Ban, M., Spillantini, M. G., Compston, A., Burn, D. J., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21192 · Cited by 270
Self-citationRakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., & Brooks, D. J. (1999) · Brain · doi:10.1093/brain/122.9.1637 · Cited by 270
Relationship of motor symptoms to intellectual deficits in Parkinson disease
Mortimer, J. A., Pirozzolo, F. J., Hansch, E. C., & Webster, D. D. (1982) · Neurology · doi:10.1212/wnl.32.2.133 · Cited by 268
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd79 · Cited by 255
Cognitive functions and corticostriatal circuits: insights from Huntington's disease
Lawrence, A. D., Sahakian, B. J., & Robbins, T. W. (1998) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(98)01231-5 · Cited by 252
Self-citationVisuospatial memory deficits at different stages of Parkinson's disease
Owen, A. M., Beksinska, M., James, M., Leigh, P. N., Summers, B. A., Marsden, C. D., Quinn, N. P., Sahakian, B. J., & Robbins, T. W. (1993) · Neuropsychologia · doi:10.1016/0028-3932(93)90135-m · Cited by 252
Self-citationMcGaughy, J., Ross, R. S., & Eichenbaum, H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.064 · Cited by 226
Parkinsonism: Effects of levodopa treatment on concept formation
BOWEN, F. P., KAMIENNY, R. S., BURNS, M. M., & YAHR, M. D. (1975) · Neurology · doi:10.1212/wnl.25.8.701 · Cited by 219
Parkinson's disease and dementia: Norepinephrine and dopamine in locus ceruleus
Cash, R., Dennis, T., L'Heureux, R., Raisman, R., Javoy-Agid, F., & Scatton, B. (1987) · Neurology · doi:10.1212/wnl.37.1.42 · Cited by 196
Bostwick, J. M., Hecksel, K. A., Stevens, S. R., Bower, J. H., & Ahlskog, J. E. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60538-7 · Cited by 183
Williams-Gray, C. H., Hampshire, A., Robbins, T. W., Owen, A. M., & Barker, R. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0774-07.2007 · Cited by 180
Self-citationLesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat
Tait, D. S., Brown, V. J., Farovik, A., Theobald, D. E., Dalley, J. W., & Robbins, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05612.x · Cited by 179
Self-citationCholinergic‐dependent cognitive deficits in Parkinson's disease
Dubois, B., Danzé, F., Pillon, B., Cusimano, G., Lhermitte, F., & Agid, Y. (1987) · Annals of Neurology · doi:10.1002/ana.410220108 · Cited by 178
A subcortico-cortical cholinergic system is affected in Parkinson's disease
Dunois, B., Ruberg, M., Javoy-Agid, F., Ploska, A., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90096-3 · Cited by 176
van Eimeren, T., Ballanger, B., Pellecchia, G., Miyasaki, J. M., Lang, A. E., & Strafella, A. P. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.124 · Cited by 163
INTELLECTUAL IMPAIRMENT IN PARKINSON'S SYNDROME
LORANGER, A. W., GOODELL, H., McDOWELL, F. H., LEE, J. E., & SWEET, R. D. (1972) · Brain · doi:10.1093/brain/95.2.405 · Cited by 161
Bentivoglio, M., & Morelli, M. (2005) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(05)80005-3 · Cited by 157
Imaging in Parkinson’s Disease: The Role of Monoamines in Behavior
Brooks, D. J., & Piccini, P. P. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.017 · Cited by 151
Kaasinen, V. (2001) · Brain · doi:10.1093/brain/124.6.1125 · Cited by 149
Marsh, L., Biglan, K., Gerstenhaber, M., & Williams, J. R. (2008) · Movement Disorders · doi:10.1002/mds.22307 · Cited by 144
Collins, P., Wilkinson, L. S., Everitt, B. J., Robbins, T. W., & Roberts, A. C. (2000) · Behavioral Neuroscience · doi:10.1037/0735-7044.114.1.3 · Cited by 129
Self-citationRecognition memory in Parkinson's disease.
Flowers, K. A., Pearce, I., & Pearce, J. (1984) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.11.1174 · Cited by 116
Understanding the dopaminergic deficits in Parkinson’s disease: Insights into disease heterogeneity
Lewis, S. J. G., & Barker, R. A. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.08.020 · Cited by 82
Self-citationAn investigation of the phenomenon of “set” in Parkinson's disease
Brown, R. G., & MARSDEN, C. D. (1988) · Movement Disorders · doi:10.1002/mds.870030207 · Cited by 81
Canavan, A. G. M., Passingham, R. E., MARSDEN, C. D., Quinn, N. P., Wyke, M., & Polkey, C. E. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90112-2 · Cited by 72
Levodopa Treatment of Parkinson's Syndrome: Improved Intellectual Functioning
Loranger, A. W., Goodell, H., LEE, J. C., & McDowell, F. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200067014 · Cited by 71
Kehagia, A. A., Cools, R., Barker, R. A., & Robbins, T. W. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.01.002 · Cited by 68
Self-citationThe role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease.
Słabosz, A., Lewis, S. J. G., Śmigasiewicz, K., Szymura, B., Barker, R. A., & Owen, A. M. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.5.578 · Cited by 61
Self-citationEvidence for a widespread dopaminergic innervation of the human cerebral neocortex
Keyser, J. D., Ebinger, G., & Vauquelin, G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90589-2 · Cited by 60
Herzallah, M. M., Moustafa, A. A., Misk, A. J., Al-Dweib, L. H., Abdelrazeq, S. A., Myers, C. E., & Gluck, M. A. (2010) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181df3048 · Cited by 26
Cools, A. R. (1984) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(84)90195-1 · Cited by 25
Cited by
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027
Parkinson’s disease dementia: a neural networks perspective
Gratwicke, J., Jahanshahi, M., & Foltynie, T. (2015) · Brain · doi:10.1093/brain/awv104 · Cited by 435
The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders
Tarafdar, A., & Pula, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123824 · Cited by 373
Liu, A. K. L., Chang, R. C.-C., Pearce, R. K. B., & Gentleman, S. M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1392-5 · Cited by 368
Metadata
- Authors
- Kehagia, A. A., Barker, R. A., & Robbins, T. W.
- Venue
- Neurodegenerative Diseases
- Publisher
- S. Karger AG
- Published
- 2012-10-03
- Volume
- 11
- Issue
- 2
- Pages
- 79-92
- ISSN
- 1660-2854 (ISSN-L)
- 1660-2862
- OpenAlex
- W1997230335
- Cited by
- 573
- References
- 82
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.